Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Infectious Diseases: News, Opinions, Training ; 11(2):8-13, 2022.
Article in Russian | EMBASE | ID: covidwho-2324869

ABSTRACT

One of the symptoms of a new coronavirus infection (COVID-19) is a complete or partial violation of the sense of smell. The aim of the work is to analyze the published results of scientific research on the mechanisms of olfactory impairment in COVID-19. Material and methods. Research was conducted for publications in Pubmed on the problem of olfactory impairment in COVID-19 using terms indexed by MeSH. The systematic review was compiled in accordance with the checklist Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA). Results. Publication's analysis has shown that the existing ideas about conductive anosmia are insufficient to explain the causes of olfactory impairment caused by SARS-CoV-2. It has been established that ACE2 and TMPRSS2 receptors located on the surface of target cells are necessary for the penetration of a new coronavirus. It is known that these receptors are mainly located on the cells of the olfactory epithelium. The main hypothesis of olfactory impairment in COVID-19 is that anosmia/hyposmia is caused by damage not to neuronal cells (as previously assumed), but to the olfactory epithelium. There is no confirmation of the point of view about the damage of SARS-CoV-2 olfactory bulbs and olfactory neurons, since they do not express receptor proteins for the virus on their surface.Copyright © 2022 by the authors.

2.
Infectious Diseases: News, Opinions, Training ; 11(2):8-13, 2022.
Article in Russian | Scopus | ID: covidwho-1955512

ABSTRACT

One of the symptoms of a new coronavirus infection (COVID-19) is a complete or partial violation of the sense of smell. The aim of the work is to analyze the published results of scientific research on the mechanisms of olfactory impairment in COVID-19. Material and methods. Research was conducted for publications in Pubmed on the problem of olfactory impairment in COVID-19 using terms indexed by MeSH. The systematic review was compiled in accordance with the checklist Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA). Results. Publication’s analysis has shown that the existing ideas about conductive anosmia are insufficient to explain the causes of olfactory impairment caused by SARS-CoV-2. It has been established that ACE2 and TMPRSS2 receptors located on the surface of target cells are necessary for the penetration of a new coronavirus. It is known that these receptors are mainly located on the cells of the olfactory epithelium. The main hypothesis of olfactory impairment in COVID-19 is that anosmia/hyposmia is caused by damage not to neuronal cells (as previously assumed), but to the olfactory epithelium. There is no confirmation of the point of view about the damage of SARS-CoV-2 olfactory bulbs and olfactory neurons, since they do not express receptor proteins for the virus on their surface. © 2022 by the authors.

3.
Science & Healthcare ; 23(2):6-12, 2021.
Article in Russian | GIM | ID: covidwho-1302943

ABSTRACT

Relevance: The COVID-19 infection caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) has rapidly escalated into a pandemic since it was first reported in December 2019. The new coronavirus is one of the highly pathogenic viruses affecting humans. To defeat this disease, it is necessary to form a collective immunity, which occurs due to the development of immunity in the population, either as a result of vaccination or as a result of a previous infection. Due to the high mortality rate and rapid spread, an effective vaccine is urgently needed to combat this pandemic. Vaccination of a significant part of the population will be required to safely achieve collective immunity against COVID-19, which will reduce the total amount of the virus that can spread among the entire population. One of the goals of vaccinating the population is to provide safety and protection against this disease for vulnerable populations who cannot be vaccinated.

SELECTION OF CITATIONS
SEARCH DETAIL